Decker MW - Search Results

1

In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease.

Bitner RS, Bunnelle WH, Decker MW, Drescher KU, Kohlhaas KL, Markosyan S, Marsh KC, Nikkel AL, Browman K, Radek R, Anderson DJ, Buccafusco J, Gopalakrishnan M. Bitner RS, et al. Among authors: decker mw. J Pharmacol Exp Ther. 2010 Sep 1;334(3):875-86. doi: 10.1124/jpet.110.167213. Epub 2010 May 26. J Pharmacol Exp Ther. 2010. PMID: 20504913

2

Effects of nicotine on spatial memory deficits in rats with septal lesions.

Decker MW, Majchrzak MJ, Anderson DJ. Decker MW, et al. Brain Res. 1992 Feb 14;572(1-2):281-5. doi: 10.1016/0006-8993(92)90485-r. Brain Res. 1992. PMID: 1611524

3

Cholinergic channel activators: novel opportunities for the treatment of CNS disorders.

Sullivan JP, Decker MW, Donnelly-Roberts D, Brioni JD, Bannon AW, Holladay MW, Anderson DJ, Briggs CA, Williams M, Arneric SP. Sullivan JP, et al. Among authors: decker mw. Proc West Pharmacol Soc. 1995;38:127-30. Proc West Pharmacol Soc. 1995. PMID: 7480004 Review.

4

Erysodine, a competitive antagonist at neuronal nicotinic acetylcholine receptors.

Decker MW, Anderson DJ, Brioni JD, Donnelly-Roberts DL, Kang CH, O'Neill AB, Piattoni-Kaplan M, Swanson S, Sullivan JP. Decker MW, et al. Eur J Pharmacol. 1995 Jun 23;280(1):79-89. doi: 10.1016/0014-2999(95)00191-m. Eur J Pharmacol. 1995. PMID: 7498257

5

Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics.

Decker MW, Brioni JD, Bannon AW, Arneric SP. Decker MW, et al. Life Sci. 1995;56(8):545-70. doi: 10.1016/0024-3205(94)00488-e. Life Sci. 1995. PMID: 7869835 Review.

6

(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.

Decker MW, Brioni JD, Sullivan JP, Buckley MJ, Radek RJ, Raszkiewicz JL, Kang CH, Kim DJ, Giardina WJ, Wasicak JT, et al. Decker MW, et al. J Pharmacol Exp Ther. 1994 Jul;270(1):319-28. J Pharmacol Exp Ther. 1994. PMID: 7913497

7

Anxiolytic-like effects of the novel cholinergic channel activator ABT-418.

Brioni JD, O'Neill AB, Kim DJ, Buckley MJ, Decker MW, Arneric SP. Brioni JD, et al. Among authors: decker mw. J Pharmacol Exp Ther. 1994 Oct;271(1):353-61. J Pharmacol Exp Ther. 1994. PMID: 7965735

8

(+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.

Sullivan JP, Decker MW, Brioni JD, Donnelly-Roberts D, Anderson DJ, Bannon AW, Kang CH, Adams P, Piattoni-Kaplan M, Buckley MJ, et al. Sullivan JP, et al. Among authors: decker mw. J Pharmacol Exp Ther. 1994 Nov;271(2):624-31. J Pharmacol Exp Ther. 1994. PMID: 7965777

9

Effects of ABT-418, a novel cholinergic channel ligand, on place learning in septal-lesioned rats.

Decker MW, Curzon P, Brioni JD, Arnerić SP. Decker MW, et al. Eur J Pharmacol. 1994 Aug 11;261(1-2):217-22. doi: 10.1016/0014-2999(94)90323-9. Eur J Pharmacol. 1994. PMID: 8001648

10

Characterization of high voltage spindles and spatial memory in young, mature and aged rats.

Radek RJ, Curzon P, Decker MW. Radek RJ, et al. Among authors: decker mw. Brain Res Bull. 1994;33(2):183-8. doi: 10.1016/0361-9230(94)90249-6. Brain Res Bull. 1994. PMID: 8275337

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

236 results

Search Page